CM
PACB icon

Caption Management’s Pacific Biosciences PACB Stock Holding History

Caption Management’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-31,200
Closed -$42.7K – 1514
2024
Q2 		$42.7K Sell
31,200
-448,500
-93% -$906K ﹤0.01% 1061
2024
Q1 		$1.8M Sell
479,700
-642,300
-57% -$3.76M 0.03% 567
2023
Q4 		$11M Buy
1,122,000
+158,000
+16% +$1.29M 0.15% 168
2023
Q3 		$8.05M Buy
964,000
+15,700
+2% +$179K 0.12% 197
2023
Q2 		$12.6M Sell
948,300
-169,400
-15% -$2.06M 0.22% 112
2023
Q1 		$12.9M Sell
1,117,700
-196,300
-15% -$1.95M 0.25% 92
2022
Q4 		$10.7M Buy
1,314,000
+1,182,600
+900% +$10.2M 0.17% 155
2022
Q3 		$763K Sell
131,400
-144,700
-52% -$830K 0.01% 957
2022
Q2 		$1.22M Buy
+276,100
New +$1.68M 0.02% 811
2021
Q1 		– Sell
-70,000
Closed -$1.81M – 1297
2020
Q4 		$1.81M Buy
+70,000
New +$1.19M 0.04% 463

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
MA
Madrone Advisors Menlo Park, California $1.03B AUM 20.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Caption Management's PACB Position: Q2 2024 in Review

Caption Management sold out of Pacific Biosciences (PACB) in Q2 2024, closing a stake of 6,400 shares — an estimated $12.9K sold.

Caption Management first reported a position in PACB in Q3 2019 and held it in 5 quarters. The position peaked at $1.19M in Q3 2023. 228 funds tracked by Wall St. Rank hold PACB as of Q2 2024.

  • Caption Management reported no remaining Pacific Biosciences position as of Q2 2024 after selling out during the quarter.
  • Caption Management sold 6,400 Pacific Biosciences shares in Q2 2024, an estimated $12.9K.
  • Caption Management first reported a position in Pacific Biosciences in Q3 2019 and held it in 5 quarters.
  • Caption Management's Pacific Biosciences position peaked at $1.19M in Q3 2023.
  • 228 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2024.

Based on Caption Management's 13F filing for Q2 2024, filed 14 Aug 2024.